Dose Optimization of Immune Checkpoint Inhibitors: A Policy opportunity to reduce costs and improve access to immunotherapy in the United States. (PubMed, J Cancer Policy) - Oct 19, 2026 - "Alternate immunotherapy dosing represents a high-value cost saving strategy to reduce health care costs and improve global access. Implementation requires regulatory adaptation, smaller vials, or vial-sharing to minimize waste."
Checkpoint inhibition • Journal • Oncology
|
|
Aakash Desai; Arthi Sridhar; Chelsee J Jensen; Daria Chelysheva; Krishna Sajeev; Nilansh Kataria; S M Qasim Hussaini; Sameer Deshmukh; Scott A Soefjie
|